Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as tremor and rigidity, along with non-motor symptoms such as cognitive decline and depression. Current dopaminergic therapies offer symptomatic relief but fail to halt disease progression, underscoring the urgent need for novel, disease-modifying therapies . This review explores the potential of repurposed drugs from different therapeutic categories—including immunomodulatory, cardiomet
No takes yet. Share an insight, caveat, or question.
Lastovetskyi et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: